Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Liraglutide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Victoza 6mg/ml solution for injection 3ml pre-filled pens
0601023ABBBAAAA
|
Victoza | Liraglutide | Endocrine System | 21,831 |
|
Liraglutide 6mg/1ml inj 3ml pre-filled disposable devices
0601023ABAAAAAA
|
Liraglutide | Liraglutide | Endocrine System | 19,962 |
|
Saxenda 6mg/ml solution for injection 3ml pre-filled pens
0601023ABBCAAAA
|
Saxenda | Liraglutide | Endocrine System | 505 |
|
Zegluxen 6mg/ml solution for injection 3ml pre-filled pens
0601023ABBEAAAA
|
Zegluxen | Liraglutide | Endocrine System | 47 |
|
Diavic 6mg/ml solution for injection 3ml pre-filled pens
0601023ABBFAAAA
|
Diavic | Liraglutide | Endocrine System | 14 |
|
Biolide 6mg/ml solution for injection 3ml pre-filled pens
0601023ABBGAAAA
|
Biolide | Liraglutide | Endocrine System | No data available |
|
Nevolat 6mg/ml solution for injection 3ml pre-filled pens
0601023ABBDAAAA
|
Nevolat | Liraglutide | Endocrine System | No data available |
|
Plaobes 6mg/ml solution for injection 3ml pre-filled pens
0601023ABBHAAAA
|
Plaobes | Liraglutide | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.